Reduced toxicity cisplatin formulations and methods for using the same
CA 2461219 A1 · Owner: Fogarty, Patrick · Inventors: Fogarty, Patrick
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods of using cisplatin active agents in which reduced host toxicity is observed are provided. In the subject methods an effective amount of a , cisplatin active agent in administered to the host in conjunction with the administration of a cisplatin toxicity reducing agent of the present invention. Also provided are compositions for use in practicing the subject methods, e.g. pharmaceutical compositions having reduced toxicity in which , the cisplatin active agent is combined with an cisplatin toxicity reducing agent that reduces the level of undesired cisplatin toxicity while maintaining an effective cisplatin anti-proliferative activity. Also provided are methods of using the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 20, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 20, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 20, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.